Literature DB >> 16988836

Subretinal neovascular membrane associated with type 2a idiopathic juxtafoveolar telangiectasis in pseudoxanthoma elasticum.

Maurizio Battaglia Parodi1, Pierluigi Iacono, Giuseppe Ravalico.   

Abstract

BACKGROUND: The objective was to report a case of pseudoxanthoma elasticum associated with type 2A idiopathic juxtafoveolar telangiectasis (T2AIJT) complicated by bilateral subretinal neovascular membranes (SRNVM).
METHODS: The right eye with juxtafoveal SRNVM and the left eye with subfoveal SRNVM underwent laser photocoagulation and photodynamic therapy respectively. The follow-up duration was 48 months.
RESULTS: Best corrected visual acuity was 20/32 in both eyes at baseline, and 20/32 in the right eye and 20/200 in the left eye at the end of the follow-up. Atrophic changes in the retinal pigment epithelium developed around the SRNVM treated with photodynamic therapy (PDT).
CONCLUSIONS: Pseudoxanthoma elasticum may be associated with T2AIJT complicated by bilateral SRNVM. Further studies are needed to assess both efficacy and appropriate PDT regime in T2AIJT-related SRNVM, especially if associated with other conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16988836     DOI: 10.1007/s00417-006-0402-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  11 in total

1.  Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis.

Authors:  Nicholas E Engelbrecht; Thomas M Aaberg; Jennie Sung; Mary Lou Lewis
Journal:  Arch Ophthalmol       Date:  2002-03

2.  Photodynamic therapy with verteporfin of choroidal neovascularization in angioid streaks: conventional versus early retreatment.

Authors:  I D Ladas; I Georgalas; A A Rouvas; S Gotsis; D A Karagiannis; M Moschos
Journal:  Eur J Ophthalmol       Date:  2005 Jan-Feb       Impact factor: 2.597

3.  Long-term juxtafoveal retinal telangiectasia.

Authors:  Robert C Watzke; Michael L Klein; James C Folk; Samuel G Farmer; Richard S Munsen; Robert J Champfer; K R Sletten
Journal:  Retina       Date:  2005-09       Impact factor: 4.256

4.  Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis.

Authors:  A S Berger; B W McCuen; G C Brown; R L Brownlow
Journal:  Retina       Date:  1997       Impact factor: 4.256

5.  Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.

Authors:  Andrew C Browning; A K K Chung; F Ghanchi; S P Harding; M Musadiq; S J Talks; Y C Yang; W M Amoaku
Journal:  Ophthalmology       Date:  2005-07       Impact factor: 12.079

6.  Photodynamic therapy with verteporfin for choroidal neovascularization associated with angioid streaks.

Authors:  Heinrich Heimann; Faik Gelisken; Joachim Wachtlin; Andreas Wehner; Michael Völker; Michael H Foerster; Karl Ulrich Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-10       Impact factor: 3.117

7.  Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy.

Authors:  Ugo Menchini; Gianni Virgili; Ugo Introini; Francesco Bandello; Massimo Ambesi-Impiombato; Alfredo Pece; Maurizio Battaglia Parodi; Giovanni Giacomelli; Benedetta Capobianco; Monica Varano; Rosario Brancato
Journal:  Retina       Date:  2004-10       Impact factor: 4.256

8.  Transpupillary thermotherapy for subfoveal neovascularization secondary to group 2A idiopathic juxtafoveolar telangiectasis.

Authors:  Dhananjay Shukla; Jatinder Singh; Chandra Mohan Kolluru; Ramasamy Kim; Perumalsamy Namperumalsamy
Journal:  Am J Ophthalmol       Date:  2004-07       Impact factor: 5.258

9.  Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.

Authors:  J D Gass; B A Blodi
Journal:  Ophthalmology       Date:  1993-10       Impact factor: 12.079

10.  Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.

Authors:  Bernadette Snyers; Claire Verougstraete; Laurence Postelmans; Anita Leys; Philip Hykin
Journal:  Am J Ophthalmol       Date:  2004-05       Impact factor: 5.258

View more
  2 in total

Review 1.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

Review 2.  Macular Telangiectasia Type 2: A Comprehensive Review.

Authors:  Kiran Chandra Kedarisetti; Raja Narayanan; Michael W Stewart; Nikitha Reddy Gurram; Arshad M Khanani
Journal:  Clin Ophthalmol       Date:  2022-10-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.